Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Toronto, Canada, Dec. 23, 2025 (GLOBE NEWSWIRE) -- In 2026, the North American gaming landscape is witnessing a seismic shift. As the market expands, Canadian players are increasingly...
Read More -
KINGSTOWN, St. Vincent and Grenadines, Dec. 24, 2025 (GLOBE NEWSWIRE) -- In a move to recognize and reward its rapidly growing community, GeeFi has unveiled a new giveaway designed to celebrate...
Read More
-
NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of F5, Inc. (NASDAQ:...
-
NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Freeport-McMoRan Inc. (NYSE: FCX) between February 15, 2022...
-
Investors who lost money in INSP after its stock plunged 32% due to allegedly misleading financial statements are urged to contact Hagens Berman.
-
Toronto, Canada, Dec. 23, 2025 (GLOBE NEWSWIRE) -- In 2026, the North American gaming landscape is witnessing a seismic shift. As the market expands, Canadian players are increasingly...
-
RejuvaKnee heated knee massager crosses 3,000 ratings as 27.5M uninsured Americans & aging Baby Boomers seek affordable at-home alternatives.
-
December 23, 2025 20:03 ET | Source: Faircourt Asset Management Inc.; Faircourt Gold Income Corp.; Faircourt Split Trust
Toronto, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Faircourt Asset Management Inc., as Manager of the Faircourt Fund (CBOE:FGX), is pleased to announce the monthly distribution payable on the Shares of the...
-
FINDLAY, OH, Dec. 23, 2025 (GLOBE NEWSWIRE) -- FINDLAY, OH - December 24, 2025 - - Dr. Andrea Adams-Miller, an applied neuroscientist, executive advisor, communication strategist, and CEO of The...
-
Analysis examines best peptides for muscle growth as ReadyRx lists prescription sermorelin in injectable and dissolving formats before 2026.
-
Agios today announced that the U.S. FDA has approved AQVESME™ (mitapivat), an oral pyruvate kinase (PK) activator, for thalassemia
-
Jackpota announces new 2025 slot releases, expanding its sweepstakes gaming library with new features, visuals, and performance across devices.